Radius, 3M Drug Delivery partner on osteoporosis drug; OptiNose wins award for nasal delivery;

> Radius Health and 3M Drug Delivery Systems are getting together to develop a transdermal version of BA058, which is Radius' parathyroid hormone-related protein analog to treat osteoporosis. Story

> OptiNose has won an innovation award in Oslo for its nasal drug delivery technology. It should be given an award for a great company name, too--second only to Cyrano Sciences and its Cyranose electronic odor detector. OptiNose release

> Serina Therapeutics has developed a new way of synthesizing polyoxazoline polymers for drug delivery applications that it says is free of the drawbacks that have hampered previous production methods. Story

> UK-based drug-delivery company Q Chip has completed a $6 million funding round, which it plans to spend on developing its bio-encapsulation and drug delivery platform for long-acting injectable therapeutics with tailored sustained-release profiles and improved administration, according to a news release. Q Chip release

> Novozymes Biopharma will launch a new grade of its Bacillus-derived hyaluronic acid for ophthalmic delivery applications later this year. Story

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.